APA (7th ed.) Citation

Nie, R., Yuan, S., Ding, Y., Chen, Y., Li, Y., Liang, C., . . . Chen, Y. Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): A prospective, nonrandomized, open-label, phase 2 trial. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Nie, Run-Cong, et al. Perioperative Tislelizumab Plus Chemotherapy for Locally Advanced Gastroesophageal Junction Adenocarcinoma (NEOSUMMIT-03): A Prospective, Nonrandomized, Open-label, Phase 2 Trial. Nature Publishing Group.

MLA (9th ed.) Citation

Nie, Run-Cong, et al. Perioperative Tislelizumab Plus Chemotherapy for Locally Advanced Gastroesophageal Junction Adenocarcinoma (NEOSUMMIT-03): A Prospective, Nonrandomized, Open-label, Phase 2 Trial. Nature Publishing Group.